Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo

H. Vlassara, M. Brownlee, A. Cerami

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

A high-affinity macrophage receptor has been shown to mediate the removal of proteins modified by advanced nonenzymatic glycosylation end products (AGEs) in both animals and humans. To characterize the effect of diabetes on this receptor system, resident peritoneal macrophages from experimentally induced and genetically diabetic mice were studied. Binding and degradation of radioiodinated AGE-bovine serum albumin (AGE-BSA) were determined from saturation kinetics and compared with glucose and insulin levels of each subgroup. Scatchard plot analysis of nondiabetic mouse macrophages had indicated 1.5 x 105 receptors/cell, with a binding affinity of 1.7 x 107 M-1. The in vitro exposure of macrophages to either elevated glucose or insulin concentrations failed to demonstrate a short-term regulatory effect on AGF-receptor function. However, macrophages from hypoinsulinemic alloxan-induced diabetic mice indicated a two- to threefold increase in AGE-receptor number per cell (2.98 ± 0.25 x 105/cell), and macrophages from C57BL/KsJ (db/db) mice showed an almost threefold greater receptor number (2.86 ± 0.2 x 105/cell), with binding affinity remaining essentially unchanged (1.24 ± 0.2 x 107 and 1.21 ± 0.07 x 107 M-1, respectively). In addition, a moderate increase (25-30%) of 125I-labeled AGE-BSA degradation was observed in these two insulin-deficient diabetic macrophage groups compared with the normal control group. In contrast, macrophages from hyperinsulinemic and hyperglycemic C57BL/6J (db/db) mice demonstrated a distinct reduction in both AGE-receptor number (0.67 ± 0.03 x 105/cell) and binding affinity (0.37 ± 0.03 x 107 M-1), with a decrease of AGE-BSA degradation of ~50% compared with the control group. This study provides evidence for a specific insulin-sensitive mechanism that modulates the function of the macrophage AGE receptors. High peripheral insulin levels may thus adversely affect the receptor-mediated clearance of nonenzymatically glycosylated proteins from sites of diabetic tissue damage.

Original languageEnglish (US)
Pages (from-to)456-461
Number of pages6
JournalDiabetes
Volume37
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Macrophages
Insulin
Bovine Serum Albumin
Glucose
Control Groups
Alloxan
Advanced Glycosylation End Products
Advanced Glycosylation End Product-Specific Receptor
Peritoneal Macrophages
Proteins
Cell Count

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. / Vlassara, H.; Brownlee, M.; Cerami, A.

In: Diabetes, Vol. 37, No. 4, 1988, p. 456-461.

Research output: Contribution to journalArticle

@article{7a595a8640654f468f8ac54129b5fc26,
title = "Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo",
abstract = "A high-affinity macrophage receptor has been shown to mediate the removal of proteins modified by advanced nonenzymatic glycosylation end products (AGEs) in both animals and humans. To characterize the effect of diabetes on this receptor system, resident peritoneal macrophages from experimentally induced and genetically diabetic mice were studied. Binding and degradation of radioiodinated AGE-bovine serum albumin (AGE-BSA) were determined from saturation kinetics and compared with glucose and insulin levels of each subgroup. Scatchard plot analysis of nondiabetic mouse macrophages had indicated 1.5 x 105 receptors/cell, with a binding affinity of 1.7 x 107 M-1. The in vitro exposure of macrophages to either elevated glucose or insulin concentrations failed to demonstrate a short-term regulatory effect on AGF-receptor function. However, macrophages from hypoinsulinemic alloxan-induced diabetic mice indicated a two- to threefold increase in AGE-receptor number per cell (2.98 ± 0.25 x 105/cell), and macrophages from C57BL/KsJ (db/db) mice showed an almost threefold greater receptor number (2.86 ± 0.2 x 105/cell), with binding affinity remaining essentially unchanged (1.24 ± 0.2 x 107 and 1.21 ± 0.07 x 107 M-1, respectively). In addition, a moderate increase (25-30{\%}) of 125I-labeled AGE-BSA degradation was observed in these two insulin-deficient diabetic macrophage groups compared with the normal control group. In contrast, macrophages from hyperinsulinemic and hyperglycemic C57BL/6J (db/db) mice demonstrated a distinct reduction in both AGE-receptor number (0.67 ± 0.03 x 105/cell) and binding affinity (0.37 ± 0.03 x 107 M-1), with a decrease of AGE-BSA degradation of ~50{\%} compared with the control group. This study provides evidence for a specific insulin-sensitive mechanism that modulates the function of the macrophage AGE receptors. High peripheral insulin levels may thus adversely affect the receptor-mediated clearance of nonenzymatically glycosylated proteins from sites of diabetic tissue damage.",
author = "H. Vlassara and M. Brownlee and A. Cerami",
year = "1988",
language = "English (US)",
volume = "37",
pages = "456--461",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo

AU - Vlassara, H.

AU - Brownlee, M.

AU - Cerami, A.

PY - 1988

Y1 - 1988

N2 - A high-affinity macrophage receptor has been shown to mediate the removal of proteins modified by advanced nonenzymatic glycosylation end products (AGEs) in both animals and humans. To characterize the effect of diabetes on this receptor system, resident peritoneal macrophages from experimentally induced and genetically diabetic mice were studied. Binding and degradation of radioiodinated AGE-bovine serum albumin (AGE-BSA) were determined from saturation kinetics and compared with glucose and insulin levels of each subgroup. Scatchard plot analysis of nondiabetic mouse macrophages had indicated 1.5 x 105 receptors/cell, with a binding affinity of 1.7 x 107 M-1. The in vitro exposure of macrophages to either elevated glucose or insulin concentrations failed to demonstrate a short-term regulatory effect on AGF-receptor function. However, macrophages from hypoinsulinemic alloxan-induced diabetic mice indicated a two- to threefold increase in AGE-receptor number per cell (2.98 ± 0.25 x 105/cell), and macrophages from C57BL/KsJ (db/db) mice showed an almost threefold greater receptor number (2.86 ± 0.2 x 105/cell), with binding affinity remaining essentially unchanged (1.24 ± 0.2 x 107 and 1.21 ± 0.07 x 107 M-1, respectively). In addition, a moderate increase (25-30%) of 125I-labeled AGE-BSA degradation was observed in these two insulin-deficient diabetic macrophage groups compared with the normal control group. In contrast, macrophages from hyperinsulinemic and hyperglycemic C57BL/6J (db/db) mice demonstrated a distinct reduction in both AGE-receptor number (0.67 ± 0.03 x 105/cell) and binding affinity (0.37 ± 0.03 x 107 M-1), with a decrease of AGE-BSA degradation of ~50% compared with the control group. This study provides evidence for a specific insulin-sensitive mechanism that modulates the function of the macrophage AGE receptors. High peripheral insulin levels may thus adversely affect the receptor-mediated clearance of nonenzymatically glycosylated proteins from sites of diabetic tissue damage.

AB - A high-affinity macrophage receptor has been shown to mediate the removal of proteins modified by advanced nonenzymatic glycosylation end products (AGEs) in both animals and humans. To characterize the effect of diabetes on this receptor system, resident peritoneal macrophages from experimentally induced and genetically diabetic mice were studied. Binding and degradation of radioiodinated AGE-bovine serum albumin (AGE-BSA) were determined from saturation kinetics and compared with glucose and insulin levels of each subgroup. Scatchard plot analysis of nondiabetic mouse macrophages had indicated 1.5 x 105 receptors/cell, with a binding affinity of 1.7 x 107 M-1. The in vitro exposure of macrophages to either elevated glucose or insulin concentrations failed to demonstrate a short-term regulatory effect on AGF-receptor function. However, macrophages from hypoinsulinemic alloxan-induced diabetic mice indicated a two- to threefold increase in AGE-receptor number per cell (2.98 ± 0.25 x 105/cell), and macrophages from C57BL/KsJ (db/db) mice showed an almost threefold greater receptor number (2.86 ± 0.2 x 105/cell), with binding affinity remaining essentially unchanged (1.24 ± 0.2 x 107 and 1.21 ± 0.07 x 107 M-1, respectively). In addition, a moderate increase (25-30%) of 125I-labeled AGE-BSA degradation was observed in these two insulin-deficient diabetic macrophage groups compared with the normal control group. In contrast, macrophages from hyperinsulinemic and hyperglycemic C57BL/6J (db/db) mice demonstrated a distinct reduction in both AGE-receptor number (0.67 ± 0.03 x 105/cell) and binding affinity (0.37 ± 0.03 x 107 M-1), with a decrease of AGE-BSA degradation of ~50% compared with the control group. This study provides evidence for a specific insulin-sensitive mechanism that modulates the function of the macrophage AGE receptors. High peripheral insulin levels may thus adversely affect the receptor-mediated clearance of nonenzymatically glycosylated proteins from sites of diabetic tissue damage.

UR - http://www.scopus.com/inward/record.url?scp=0023888611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023888611&partnerID=8YFLogxK

M3 - Article

C2 - 2837419

AN - SCOPUS:0023888611

VL - 37

SP - 456

EP - 461

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -